Carisma Therapeutics Inc. Assets, Fair Value Disclosure
Carisma Therapeutics Inc. had Assets, Fair Value Disclosure of $50.44 million as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2019-03-01
- 2018-12-31: Assets, Fair Value Disclosure $50.44M.
- 2017-12-31: Assets, Fair Value Disclosure $14.69M.
- 2016-12-31: Assets, Fair Value Disclosure $25.35M.
- 2016-09-30: Assets, Fair Value Disclosure $30.72M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2018-12-31 | $50.44M 10-K · filed 2019-03-01 | |
| 2017-12-31 | $14.69M 10-K · filed 2019-03-01 | |
| 2016-12-31 | $25.35M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $30.72M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $8.48M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $13.42M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $36.17M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $46.36M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $53.49M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $45.55M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $54.15M 10-K · filed 2016-03-25 | $54.06M 10-K · filed 2015-03-06 |
| 2014-09-30 | $35.94M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $45.03M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $53.96M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $7.94M 10-K · filed 2015-03-06 |